Formulation Index

Dissolution Testing and Acceptance Criteria for Immediate-Release Solid Oral Dosage Form Drug Products Containing High Solubility Drug Substances

March 23, 2019 0 Comments

The US Food and Drug Administration (FDA) on Wednesday released final guidance for sponsors on when a standard release test and criteria may be used in…

CRIZOTINIB (XALKORI)

March 23, 2019 0 Comments

Crizotinib HDPE Bottle Crizotinib capsules 200 mg Crizotinib capsules 250 mg …

Formulation Index

Dissolution Testing and Acceptance Criteria for Immediate-Release Solid Oral Dosage Form Drug Products Containing High Solubility Drug Substances

CRIZOTINIB (XALKORI)

Report Abuse

Dissolution Testing and Acceptance Criteria for Immediate-Release Solid Oral Dosage Form Drug Products Containing High Solubility Drug Substances

Popular

Recents

Comments

Contact Form